logo-loader

Alliance Pharma extends manufacturing contract with Venture Life

Published: 08:43 09 May 2018 BST

Body
Alliance has 90 healthcare products in its stable

Alliance Pharma plc (LON:ALP) has extended its manufacturing contract with AIM-listed Venture Life PLC (LON:VLG).

Venture Life already manufactures numerous products for Alliance and the agreement confirms the extension of these arrangements to 31 December 2025.

READ: Alliance Pharma to bank £2.9mln from the sale of Chinese rights to pregnancy supplement

New products are part of the extended contract and these will bring in at least €1.6mlin in additional revenue annually. 

Alliance has a portfolio of 90 healthcare products sold in more than 100 countries and is one of Venture Life's significant customers.

The new products are set to come onstream later this year, while the contract also offers Venture Life the opportunity to pitch for future new business put out to tender by Alliance. 

Oriole Resources outlines 2023 achievements and future exploration plans

Oriole Resources PLC (AIM:ORR) CEO Tim Livesey and chief financial officer Bob Smeeton join Proactive's Stephen Gunnion with details of the company's 2023 financial and operational performance. Livesey highlighted successful exploration programs in Cameroon, at the Bibemi and Mbe projects,...

34 minutes ago